• 23andMe CEO Goes Beyond “Wall Of A White Coat”

    Bio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.

    Jan 15, 2018

  • JP Morgan 2018 News Roundup

    Bio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.

    Jan 12, 2018

  • Nonprofit Price For New Childhood Blindness Therapy 4X Too High

    STAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.

    Jan 12, 2018

  • Illumina Announces iSeq 100, Thermo Fisher Partnership

    Bio-IT World  In the company’s JP Morgan presentation today, Illumina president and CEO Francis deSouza summarized the past year for the sequencing giant, highlighted expected areas of growth—consumer genomics, non-invasive prenatal testing—and announced the launch of the iSeq 100 Sequencing System and library prep partnership with Thermo Fisher.

    Jan 8, 2018

  • Genomics England Uses DRAGEN Pipeline To Re-Analyze 5000 Whole Genomes

    Bio-IT World Brief  Genomics England is currently using Edico Genome’s DRAGEN analysis pipeline to re-process 5,000 whole human genomes from individuals with rare diseases. Genomics England and Edico announced the partnership today at the annual J.P. Morgan Healthcare Conference.

    Jan 8, 2018

  • At Least Three Billion Computer Chips Have the Spectre Security Hole

    MIT Technology Review | Tech companies are still working overtime on patching two critical vulnerabilities in computer chips that were revealed this week.

    Jan 5, 2018

  • Foxconn Builds Taiwan’s Largest Supercomputer

    TOP500 | A six-petaflop system has been installed at Taiwan's Kaohsiung Software Technology Park, making it the most powerful supercomputer in the country.

    Jan 5, 2018

  • Microsoft Acquires Avere Systems File-Storage Vendor For Windows And Linux

    ZDNet | Microsoft plans to integrate Avere's file system and caching technologies for Windows and Linux clients with its Azure cloud.

    Jan 3, 2018

  • Synthego, DNAnexus, PAREXEL, And More: News From December 2017

    Bio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Synthego, DNAnexus, PAREXEL, and more.

    Jan 3, 2018

  • Blockchain, Data Storage: The Future Is Decentralized

    Dataconomy | As we look ahead to a new, decentralized internet, it is important to consider one of its most important elements: decentralized storage.

    Jan 2, 2018

  • Using Patent Data For Drug Development

    Bio-IT World Contributed Commentary | Unlocking the power of patent data is a smart, cost effective way to help mitigate the risk of developing new drugs.

    Jan 2, 2018

  • Top 10 Stories Of 2017: CRISPR, Best Practices, And More

    Bio-IT World | As we head into 2018, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2017.

    Dec 27, 2017

  • Text Mining Life Science Abstracts Vs. Full-Text Articles

    Bio-IT World Contributed Commentary | Because article abstracts are easily accessible through databases, many researchers rely on abstracts for text mining rather than sourcing full-text articles. However, new research from bioinformaticians at the University of Copenhagen and the University of Denmark confirm that essential information remains hidden when only abstracts are mined.

    Dec 20, 2017

  • The First CRISPR Clinical Trial Could Begin in 2018

    Futurism | For the first time ever, a CRISPR clinical trial has been applied for and will hopefully prove that the gene-editing technique truly holds potential.

    Dec 19, 2017

  • Year In Review: 2017 Conferences, Discussions, Awards

    Bio-IT World | A look back at the conferences held by Cambridge Healthtech Institute, covering a wide range of content focusing on bringing members of the biotech, next generation sequencing, IT, and personalized medicine communities to come together to promote innovation at the intersection between biology and technology.

    Dec 19, 2017

  • Engaging The Black Box: How AI Changes The Stakes For Pharma

    Bio-IT World Contributed Commentary | Pharmaceutical and biotechnology companies  are looking to leverage AI to reverse the decline in R&D productivity that has persisted in the face of other IT technologies, such as structure-based drug design or bioinformatics.

    Dec 14, 2017

  • Gamers Help Researchers Tackle The Problem Of Protein Folding

    Bio-IT World | Foldit is an online puzzle video game designed to fold the structures of selected proteins as perfectly as possible. Recently, the developers of the game have been partnering with companies and institutions, including Mars Incorporated and Thermo Fisher Scientific, to help target the issue of carcinogens in food.

    Dec 13, 2017

  • Researchers At Mount Sinai, Sema4 Develop Powerful New Method For Microbiome Analysis

    Bio-IT World Brief | Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.

    Dec 12, 2017

  • Race And Ancestry: Distinguishing The Two For Genetic Studies

    Bio-IT World | The findings from a study elucidating the differences in molecular alterations in multiple myeloma as a function of self-reported race and genetic ancestry were recently published in PLOS Genetics.

    Dec 11, 2017

  • The Biotech Industry Needs To Pay More Attention To Women's Health

    STAT | In this opinion piece, the authors argue that reversing the dearth of investment in women's health would be good for women, for the biotech industry, and for the U.S. economy.

    Dec 8, 2017